iifl-logo-icon 1

Dr Reddys Laboratories Ltd Futures Share Price

1,192.8
(-1.70%)
Nov 21, 2024|03:29:59 PM

Here's the list of Dr Reddys Labs's futures contracts. The future contract comprises financial derivative contracts that bind parties to buy and sell an asset at a specified future timeand price. Know the difference in strike price, quantity, expiration date and other details about the Dr Reddys Labs's futures contract.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open1,173
  • Day's High1,208.95
  • Spot1,192.8
  • Prev. Close1,214.7
  • Day's Low1,173
  • ViewShort BuildUp
  • Market Lot625
  • OI(Chg %)45,000 (0.5%)
  • Roll Over%0.28
  • Roll Cost0.74
  • Traded Vol.24,04,375 (31.7%)

Dr Reddys Labs: Related NEWS

Dr Reddy’s Bollaram Facility Receives USFDA Form 483 with 7 Observations
21 Nov 2024|11:14 PM

Dr Reddy’s Laboratories shares has gained a total of 5.62% in the last one year, and 2.45% since the beginning of the year.

Read More
Top Stocks for today - 21st November 2024
21 Nov 2024|07:53 AM

Here are some of the stocks that may see significant price movement today: UPL, Tata Power, JSW Steel, Dr Reddy’s, etc.

Read More
Dr Reddy’s posts 15% y-o-y decline in Q2 net profit at ₹1,255 Crore
6 Nov 2024|09:25 AM

EBITDA for the quarter increased 5% year-on-year to ₹2,280 Crore between July and September 2024, while margins improved modestly to 28.4%.

Read More
Top stocks for today - 6th November 2024
6 Nov 2024|08:08 AM

Here are some of the stocks that may see significant price movement today: Dr Reddy’s, Hindustan Zinc, Titan Company, etc.

Read More
Top 10 stocks for today – 11th October, 2024
11 Oct 2024|08:56 AM

Here are some of the stocks that may see significant price movement today: Mazagon Dock Shipbuilders, Krsnaa Diagnostics, Dr Reddy's, etc.

Read More
Dr Reddy’s subsidiary gets positive outcome for CAR-T cell trial
9 Oct 2024|03:48 PM

The experiment also had a favourable safety profile, with no serious adverse effects such as Cytokine Release Syndrome (CRS) or neurotoxicity reported.

Read More
Dr. Reddy’s Secures Licensing Deal with Gilead for Lenacapavir in 120 Countries
3 Oct 2024|11:12 AM

The agreement also includes a provision for Dr. Reddy’s to manufacture and commercialize Lenacapavir for HIV prevention (PrEP) in the same 120 countries, pending approval.

Read More
Top 10 stocks for today – 30th September 2024
30 Sep 2024|09:10 AM

Here are some of the stocks that may see significant price movement today: Welspun Enterprises, IDFC First Bank, Dr Reddy’s Laboratories, etc.

Read More
Dr Reddy's Hyderabad Facility Passes USFDA Inspection
23 Sep 2024|11:43 AM

This inspection success at Bachupally, combined with steady financial performance, reinforces Dr Reddy's position as a key player in the pharmaceutical industry.

Read More
Top 10 stocks for today – 23rd September 2024
23 Sep 2024|09:34 AM

Here are some of the stocks that may see significant price movement today: HFCL, Aster DM Healthcare, Tata Steel, Glenmark Pharma, etc.

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp